Polyamory is having a moment. Glowing pieces in mainstream media outlets like The New York Times and New York magazine, not ...

A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.

It’s no surprise, then, that AI has a real knack for discrimination, often exacerbating prejudice on the basis of race, ...

At a time when we are surrounded by fakes and fabrications, Sora seems precisely designed to further erode the idea of ...

Results from the phase 2 (dose optimization) part of the REJOICE-Ovarian01 phase 2/3 trial showed that raludotatug deruxtecan (R-DXd) demonstrated clinically meaningful response rates in patients with ...